• Korean Journal of Veterinary Research
• /
• v.37 no.4
• /
• pp.899-909
• /
• 1997

The aim of this study was to assess the estimates of the time of ovulation and mating derived by plasma progesterone concentration. The 40 mature Korea Jin-do bitches were monitored to determine the plasma progesterone concentrations from proestrus to parturition. Gestation length in the 30 pregnant bitches was $63.9{\pm}2.3$ ($mean{\pm}SD$) days in multiparous bitches and $61.8{\pm}3.6$ days in primiparous bitches when Day 0 was timed from the first day of male acceptance, and $61.4{\pm}1.8$ days and $61.3{\pm}2.7$ days when Day 0 was timed from the day of first mating, respectively. Also, gestation length was $63.1{\pm}1.4$ days, $62.4{\pm}1.1$ days and $61.5{\pm}0.9$ days in multiparous bitches, and $62.6{\pm}1.4$ days, $62.4{\pm}2.0$ days and $61.6{\pm}2.3$ days in primiparous bitches when Day 0 was timed from the day that plasma progesterone concentration was first increased above 2.0, 3.0 and 4.0ng/ml, respectively, and $53.8{\pm}3.1$ days and $54.8{\pm}2.6$ days when Day 0 was timed from the last day of male acceptance, respectively. In 30 pregnant bitches, plasma progesterone concentration was $0.2{\pm}0.2ng/ml$ in multiparous bitches and $0.7{\pm}0.8ng/ml$ in primiparous bitches at the first day of vulval bleeding, $1.9{\pm}1.0$ and $3.3{\pm}2.7ng/ml$ at the first day of male acceptance, $7.0{\pm}4.0$ and $9.3{\pm}6.2ng/ml$ at the day of first mating, and $25.1{\pm}6.3$ and $22.8{\pm}10.3ng/ml$ at the last day of male acceptance, respectively. When Day 0 was timed from the day of parturition, plasma progesterone concentration at Day -62, Day -63 and Day -64 was $4.7{\pm}2.7ng/ml$, $3.5{\pm}2.2ng/ml$ and $1.7{\pm}0.9ng/ml$ in multiparous bitches, and $5.3{\pm}4.4ng/ml$, $3.2{\pm}3.7ng/ml$ and $2.0{\pm}1.9ng/ml$ in primiparous bitches, respectively. When Day 0 was timed from the day that plasma progesterone concentration was first increased above 3.0ng/ml after the first day of vulval bleeding, plasma progesterone concentration at Day 61 and Day 62 was $2.7{\pm}2.2ng/ml$ and $1.4{\pm}1.9ng/ml$ in multiparous bitches, and $3.4{\pm}5.2ng/ml$ and $3.7{\pm}5.6ng/ml$ in primiparous bitches, and $0.8{\pm}0.7ng/ml$ and $0.9{\pm}0.4ng/ml$ at Day 63, respectively. It was that bitches were mated when plasma progesterone concentraion was 1.9 to 14.2ng/ml and 3.5 to 20.0ng/ml in multiparous and primiparous bitches, which was between first day before ovulation and fourth day after ovulation. And pregnancy rate was 92% (23/25). From these data, ovulation was estimated to occur the day when plasma progesterone concentration was first increased above 3.0ng/ml after the first day of vulval bleeding. It was estimated that mating time was the day when plasma progesterone concentration was between 1.9 and 20.0ng/ml, and best time for mating was between 3.0 and 8.0ng/ml of plasma progesterone concentration.

• Current Research on Agriculture and Life Sciences
• /
• v.1
• /
• pp.189-194
• /
• 1983

To investigate the effect of testosterone upon the body weight, feed intake, and creatinine and cholesterol content in the blood plasma, thirty rats which were three months old, were assigned into 6 groups of 5 rats. Those groups included one control group and 5 castrated groups which injected 0 to 4mg of testosterone each. The body weight gain in the control showed relatively higher value than the castrated, showing no significant effect between the groups. Also no significant effect in the feed intake between the groups, due to the amount of testosterone injection, was found. The creatinine content in the plasma showed a highly significant effect between the groups, giving a lower concentration in the castrated group compared with the control while the content in the hormone treated groups increased with increasing amount of testosterone injection. Otherwise the cholesterol concentration in the plasma was inversely proportional to the creatinine in each group.

• Animal cells and systems
• /
• v.6 no.3
• /
• pp.239-245
• /
• 2002

Plasma melatonin, thyroid-stimulating hormone (TSH) and body temperature were measured simultaneously and continuously before and after the sleep-wake cycle was shifted in 4 healthy males and changes in the circadian rhythm itself and in the phase relationship among these circadian rhythms were determined. Normal sleep-wake cycle (sleep hours: 2300-0700) was delayed by 10 h (sleep hours: 0900-1700) during the experiment. Even after this shift the typical melatonin rhythm was maintained: low during daytime and high during night. The melatonin rhythm was gradually delayed day by day. The TSH rhythm was also maintained fundamentally during 3 consecutive days of altered sleep-wake cycle. The phase was also delayed gradually but remarkably. The daily rhythm of body temperature was changed by the alteration of sleep-wake cycle. The body temperature began to decrease at the similar clock time as in the control but the decline during night awake period was less steep and the lowered body temperature persisted during sleep. The hormonal profiles during the days of shifted sleep/wake cycle suggest that plasma melatonin and TSH rhythms are basically regulated by an endogenous biological clock. The parallel phase shift of melatonin and TSH upon the change in sleep-wake cycle suggests that a common unitary pacemaker probably regulates these two rhythms. The reversal phase relationship between body temperature and melatonin suggests that melatonin may have a hypothermic effect on body temperature. The altered body temperature rhythm suggests that the awake status during night may inhibit the circadian decrease in body temperature and that sleep sustains the lowered body temperature. It is probable but uncertain that there ave causal relationships among sleep, melatonin, TSH, and body temperature.

• Asian-Australasian Journal of Animal Sciences
• /
• v.24 no.7
• /
• pp.940-945
• /
• 2011

In order to determine whether oxalate from grasses affects feed intake, blood calcium (Ca) and other blood parameters of adult sheep, two feeding trials were conducted. In Trial 1, one group of sheep received guineagrass (0.47% soluble oxalate) and another group received setaria (1.34% soluble oxalate) for 28 d. In Trial 2, one group of sheep received guineagrass while another group received the same grass treated with an oxalic acid solution (at a rate of 30 g oxalic acid/kg dry matter of hay) for 72 d. All sheep received concentrate mixtures (0.5% of body weight) throughout the experiment. In both trials, it was observed that plasma Ca concentration (11.0-11.7 mg/dl) was significantly (p<0.05) lower in sheep fed high oxalate-containing grasses than in sheep fed low oxalate-containing grasses (12.4-13.7 mg/dl). No differences (p>0.05) were observed in concentrations of magnesium, phosphorus and parathyroid hormone in plasma between the feeding of low and high oxalate-containing grasses. In addition, no differences (p>0.05) were observed in roughage dry mater (DM) intake, total DM intake or body weight of sheep. This study suggests that sheep may consume oxalate-rich forage, but Ca bioavailability may decrease with increasing oxalate levels in the ration.

• Preventive Nutrition and Food Science
• /
• v.16 no.2
• /
• pp.110-116
• /
• 2011

This study examined the growth effects of yeast hydrolysate (YH) and a traditional Korean herbal mixture (HM, a mixture of safflower seed and gasiogapi extract). Three-week old male SD rats were divided into the following five groups: negative control (saline), positive control (foremilk 0.5 g/kg/day), YH (YH 0.5 g/kg/day), HM (HM 0.2 g/kg/day), and YH+HM (YH 0.5 g/kg/day and HM 0.2 g/kg/day). Tibia bone length was 9.22 mm in the normal control rats, while both the YH and YH+HM groups had significantly longer tibia bones than the control rats (9.75 mm and 10.46 mm, respectively). The proximal epiphyses of YH, HM, and YH+HM measured 0.75, 0.70, and 0.75 mm, respectively, while the length in the control group was 0.50 mm. Plasma insulin growth factor-1 (IGF-1) level was slightly higher in the YH group (1.36 mg/mL) than in the control rats (1.29 mg/mL), but the difference was not significant. Plasma IGF-1 level was significantly increased in the HM (1.49 mg/mL) and YH+HM (1.53 mg/mL) groups compared to the control group (1.29 mg/mL). Growth hormone (GH) levels in YH (17.45 ng/mL), HM (15.49 ng/mL), and YH+HM (16.07 ng/mL) were significantly different compared to the control group (3.63 ng/mL).

• Biomedical Science Letters
• /
• v.17 no.3
• /
• pp.245-251
• /
• 2011

This study was conducted to investigate the effect of soybean peptide on muscle damage index and hormone (testosterone and cortisol) concentration. Subjects of this study were 23 high school male taekwondo players who had participated in regular exercise. They were randomly divided into two groups, one group took soybean peptide (S-peptide, n=13) 4 g a day for 4 weeks and the other took placebo (placebo, n=10) for the same time. We obtained blood samples before and after experiment and analyzed for CPK (Creatine phosphokinase), LDH (Lactate dehydrogenase), ALD (Aldolase), myoglobin, testosterone and cortisol. As for body composition, there was no significant difference in weight, body fat rate and LBM (lean body mass) between the S-peptide and the S-peptide group and placebo group. In CPK, LDH, ALD and myoglobin, S-peptide group was significantly lower than the placebo group and showed significant decrease before and after intaking soybean peptide (P<0.05~0.01). In the concentration of plasma testosterone, S-peptide group was increased from two weeks but not significant difference. The concentration of plasma cortisol showed significantly decrease in the S-peptide (P<0.01). These results indicate that the intake of soybean peptide have positive effect on index of muscle damage and changes of hormone concentration.

• Asian-Australasian Journal of Animal Sciences
• /
• v.21 no.10
• /
• pp.1473-1478
• /
• 2008

An experiment was conducted to investigate the mechanism for the effect of tetrabasic zinc chloride (TBZC) in enhancing growth performance of weanling piglets. Gut-brain peptides play an important role in the regulation of growth and appetite in animals. This study evaluated the effects of TBZC on blood concentrations of growth hormone (GH), ghrelin, insulin-like growth factor-I (IGF-I), cholecystokinin (CCK) and neuropeptide Y (NPY). Seventy-two weanling piglets (Landrace$\times$Large White) with an initial body weight (BW) of $6.7{\pm}0.16kg$ and aged $24{\pm}1days$ were assigned to three dietary treatments: i) control diet without TBZC supplement, ii) the control diet supplemented with 2,000 mg Zn from TBZC/kg and iii) TBZC-supplemented diet pair-fed with respect to the control diet. Each treatment had six replications (pens) of four piglets. At the end of a 14-d experimental period, piglets were weighed and feed consumption was measured, and blood samples were collected for assays of GH, ghrelin, IGF-I, CCK and NPY concentrations. The inclusion of TBZC in the diet increased average daily gain (p<0.01), average daily feed intake (p<0.05), and feed conversion ratio (p<0.05). Pair-fed piglets had higher ADG, and lower FCR than (p<0.05) Control piglets. Supplementation of the diet with TBZC increased (p<0.05) serum GH and plasma ghrelin levels in weanling piglets, but did not affect (p>0.05) serum IGF-I and plasma NPY and CCK concentrations. Pair-fed piglets had lower (p<0.05) serum GH levels than TBZC-supplemented piglets, but did not (p>0.05) differ from Control piglets. These data indicated that TBZC elevated the concentration of ghrelin and GH. This observation may partly explain the beneficial effects of TBZC on growth performance of weanling piglets.

• Journal of Nutrition and Health
• /
• v.42 no.4
• /
• pp.309-317
• /
• 2009

As far as we know, there were no studies of the effect of L-arginine on bone metabolism in post-menopausal women or ovariectomized rats. The primary objective of the current study was to determine whether arginine supplementation was associated with alterations in femoral and spinal bone mineral density (BMD) and bone markers in ovariectomized (Ovx) rats. Forty female Sprague-Dawley rats were divided into two groups, Ovx and sham groups, which were each randomly divided into two subgroups that were fed control and arginine supplemented diet. All rats were fed on experimental diet and deionized water ad libitum for 9 weeks. Bone formation was measured by serum osteocalcin and alkaline phosphatase (ALP) concentrations. Bone resorption was measured by deoxypyridinoline (DPD) crosslinks immunoassay and corrected for creatinine. Serum osteocalcin, growth hormone, insulin-like growth factor-1 (IGF-1), parathyroid hormone (PTH) and calcitonin were analyzed using radioimmunoassay kits. Bone mineral density (BMD) and bone mineral content (BMC) were measured using PIXImus (GE Lunar Co, Wisconsin, USA) in spine and femur. The serum and urine concentrations of Ca and P were determined. The plasma was analyzed for arginine. Diet did not affect weight gain, mean food intake, and plasma arginine concentration. Urinary Ca excretion was decreased by arginine supplementation in Ovx rats, but statistically not significant. The Ovx rats fed arginine-supplemented diet were not significantly different in ALP, osteocalcin, crosslinks value, PTH, calcitonin and IGF-1 compared to those fed control diet. The arginine-supplemented group had significantly higher serum Ca and growth hormone than control group. Spine and femur BMD were significantly increased by arginine supplementation on 5th and 9th weeks after feeding. Our findings indicate that dietary L-arginine supplementation decreased bone mineral density loss in Ovx rats. Therefore, dietary arginine supplementation may represent a potentially useful strategy for the management of osteoporosis.

• Journal of Nutrition and Health
• /
• v.50 no.6
• /
• pp.578-584
• /
• 2017

Purpose: Excess intake of sodium is a major diet-related risk factor for human diseases including hypertension and cancer as well as obesity and inflammation. However, findings are still controversial, and evidence is lacking in Koreans. Therefore, for better understanding of the role of dietary sodium intake in disease etiology, this study investigated the effects of dietary sodium intake on adiposity, inflammation, and hormones in Koreans. Methods: A total of 80 males and females joined the study. The general characteristics and dietary intake data were investigated by trained interviewers using a questionnaire and 24-h dietary recall, respectively. For the markers of adiposity, body weight, body mass index, percent of body fat, visceral fat area, and waist and hip circumference were measured. For the inflammation and hormone markers, leptin, adiponectin, insulin, tumor necrosis $factor-{\alpha}$, and interleukin-6 were also analyzed. Results: Multivariate linear regression analyses suggested that dietary sodium intake was not associated with adiposity. However, dietary sodium showed a significant association with insulin level: Plasma insulin concentration increased with sodium intake independent of other dietary intake or percent of body fat (${\beta}=0.296$, adjusted $r^2=0.276$, p < 0.01). Other markers for inflammation and hormonal responses were not associated with dietary sodium intake. Conclusion: Findings suggested that dietary sodium intake may be a critical modifying factor in the level of plasma insulin. However, it showed a limited effect on obesity and other inflammation markers and hormone levels. These findings should be confirmed in larger, well-designed investigations.

• Asian-Australasian Journal of Animal Sciences
• /
• v.16 no.8
• /
• pp.1188-1192
• /
• 2003

Negative feedback on GH responses to GH-releasing hormone (GHRH) and GH-releasing peptides (GHRPs) has been reported and this action has been suggested to act through an increase in somatostatin. To determine whether the acute administration of porcine GH (pGH) inhibits GH responsiveness to GHRP-2 and GHRH in swine, swine were intravenously administered with pGH (5${\mu}g$/kg BW) or placebo followed 180 min later by a second intravenous administration of saline, GHRP-2 (30 ${\mu}g$/kg BW), GHRH (1${\mu}g$/kg BW) and a combination of GHRP-2 and GHRH. Plasma GH concentration was measured by radioimmunoassay. Administration of pGH caused a significant increase in GH area under curve and GH peak concentrations (p<0.001) over placebo-treated group. Plasma GH concentrations peaked at 15 min and returned to baseline level within 90 min. Pretreatment of pGH abolished (p<0.01) GH response to GHRH and attenuated (p<0.05) GH response to GHRP-2 and GHRH combined, without affecting GH response to GHRP-2. These results demonstrate that negative feedback action on GH releasing effect of GHRH occurs in swine, and that GHRP-2 has ability to interact in this action.